Annual Accounts Payable
$1.20 M
-$1.77 M-59.66%
31 December 2023
Summary:
Cyclerion Therapeutics annual accounts payable is currently $1.20 million, with the most recent change of -$1.77 million (-59.66%) on 31 December 2023. During the last 3 years, it has fallen by -$237.00 thousand (-16.52%). CYCN annual accounts payable is now -63.82% below its all-time high of $3.31 million, reached on 31 December 2019.CYCN Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$304.00 K
-$347.00 K-53.30%
30 September 2024
Summary:
Cyclerion Therapeutics quarterly accounts payable is currently $304.00 thousand, with the most recent change of -$347.00 thousand (-53.30%) on 30 September 2024. Over the past year, it has dropped by -$510.00 thousand (-62.65%). CYCN quarterly accounts payable is now -96.54% below its all-time high of $8.78 million, reached on 30 June 2019.CYCN Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CYCN Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -59.7% | -62.6% |
| 3 y3 years | -16.5% | -74.1% |
| 5 y5 years | -56.9% | -93.9% |
CYCN Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -59.7% | at low | -92.3% | at low |
| 5 y | 5 years | -63.8% | at low | -93.9% | at low |
| alltime | all time | -63.8% | at low | -96.5% | at low |
Cyclerion Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $304.00 K(-53.3%) |
| June 2024 | - | $651.00 K(-12.1%) |
| Mar 2024 | - | $741.00 K(-38.1%) |
| Dec 2023 | $1.20 M(-59.7%) | $1.20 M(+47.2%) |
| Sept 2023 | - | $814.00 K(-56.3%) |
| June 2023 | - | $1.86 M(-52.5%) |
| Mar 2023 | - | $3.92 M(+32.2%) |
| Dec 2022 | $2.97 M(+62.5%) | $2.97 M(+80.5%) |
| Sept 2022 | - | $1.65 M(-40.5%) |
| June 2022 | - | $2.77 M(+9.8%) |
| Mar 2022 | - | $2.52 M(+37.8%) |
| Dec 2021 | $1.83 M | $1.83 M(+55.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $1.17 M(-15.3%) |
| June 2021 | - | $1.39 M(+26.6%) |
| Mar 2021 | - | $1.09 M(-23.7%) |
| Dec 2020 | $1.44 M(-56.7%) | $1.44 M(-22.6%) |
| Sept 2020 | - | $1.85 M(-28.3%) |
| June 2020 | - | $2.59 M(+70.0%) |
| Mar 2020 | - | $1.52 M(-54.0%) |
| Dec 2019 | $3.31 M(+19.1%) | $3.31 M(-33.8%) |
| Sept 2019 | - | $5.00 M(-43.0%) |
| June 2019 | - | $8.78 M(+54.9%) |
| Mar 2019 | - | $5.67 M(+103.9%) |
| Dec 2018 | $2.78 M(+54.3%) | $2.78 M |
| Dec 2017 | $1.80 M | - |
FAQ
- What is Cyclerion Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Cyclerion Therapeutics?
- What is Cyclerion Therapeutics annual accounts payable year-on-year change?
- What is Cyclerion Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Cyclerion Therapeutics?
- What is Cyclerion Therapeutics quarterly accounts payable year-on-year change?
What is Cyclerion Therapeutics annual accounts payable?
The current annual accounts payable of CYCN is $1.20 M
What is the all time high annual accounts payable for Cyclerion Therapeutics?
Cyclerion Therapeutics all-time high annual accounts payable is $3.31 M
What is Cyclerion Therapeutics annual accounts payable year-on-year change?
Over the past year, CYCN annual accounts payable has changed by -$1.77 M (-59.66%)
What is Cyclerion Therapeutics quarterly accounts payable?
The current quarterly accounts payable of CYCN is $304.00 K
What is the all time high quarterly accounts payable for Cyclerion Therapeutics?
Cyclerion Therapeutics all-time high quarterly accounts payable is $8.78 M
What is Cyclerion Therapeutics quarterly accounts payable year-on-year change?
Over the past year, CYCN quarterly accounts payable has changed by -$510.00 K (-62.65%)